تحليلات المنتج الاختيارية
بإذنك، نستخدم تحليلات محدودة تراعي الخصوصية لفهم مسارات البحث الفعالة. لا نستخدم أدوات تتبع إعلانية أو تسجيل الجلسات. يمكنك تغيير هذا الخيار في التفضيلات. اقرأ سياسة الخصوصية.
CME Group Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $109.6B | |
|---|---|---|
| Revenue (ttm) | 7B | |
| Net income (ttm) | 4.4B | |
| EPS (ttm) | $12.2 | |
| Shares out | 357.9M | |
| P/E (trailing) | 24.1x | |
| P/E (forward) | 23.5x | |
| Dividend | $11.4 (3.86%) | |
| Volume | 996,802 | |
| Beta | 0.27 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B | +8.6% |
| Gross profit | $3.85B | $4.27B | $4.75B | $5.28B | $5.61B | +9.9% |
| Operating income | $3.54B | $3.65B | $4.31B | $4.70B | $5.50B | +11.7% |
| Net income | $2.64B | $2.69B | $3.23B | $3.53B | $4.07B | +11.5% |
| EPS (diluted) | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 | +11.2% |
| EBITDA | $3.93B | $4.02B | $4.67B | $5.04B | $5.83B | +10.4% |
| R&D | — | — | — | — | — | — |
| SG&A | $151.7M | $137.4M | $144.4M | $132.7M | $150.5M | -0.2% |
Recent company headlines from major financial publishers.
Prolonged macroeconomic uncertainty, fluctuating interest rates, and geopolitical shifts drive record hedging activity and volume across CME's product suite. The company pushes through pricing increases uninhibited, scaling margins further and driving low-double-digit EPS growth.
CME Group benefits from near-monopoly network effects in interest rate, energy, and agricultural derivatives. Its vertically integrated clearinghouse acts as a massive competitive barrier. As a mature compounder, it generates extraordinary margins and massive free cash flow.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.1% | $313 | $347 | $389 | $444 | $457 |
| 8.1% | $261 | $285 | $313 | $347 | $389 |
| 9.1% | $224 | $241 | $261 | $285 | $313 |
| 10.1% | $196 | $209 | $224 | $241 | $261 |
| 11.1% | $175 | $185 | $196 | $209 | $224 |
Upcoming earnings date and setup when available.
التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.
| السنة | يناير | فبراير | مارس | أبريل | مايو | يونيو | يوليو | أغسطس | سبتمبر | أكتوبر | نوفمبر | ديسمبر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
